Top 21 VectivBio investors
The most complete profiles first. Showing 21 of 21.
Brian AtwoodVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsCybersecurityWomen FoundedPortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more
Verified email available
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Alexander MaywegVerified
Venture Capital, Private Equity Firm · Switzerland
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Verified email available
Daniel OmsteadVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carlo Rizzuto
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more
Contact details available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Charles Warden
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Ross Jaffe
Venture Capital, Investor · United States
Series BHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Beckie Robertson
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Bill Link
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Don Milder
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Jason Akus
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Contact details available
Paul Grayson
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many VectivBio investors are on Angel Roster?
Angel Roster lists 21 VectivBio investors. 8 of them (38%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16) and Private Equity Firms (14). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do VectivBio investors invest in?
Among those that list a stage, the most common are Seed (8), Series A (5) and Series B (1).
Where are VectivBio investors based?
Most are based in the United States (17), Israel (2) and Switzerland (1).
Which companies have VectivBio investors backed?
The most-backed portfolio companies among them are Century Therapeutics (19), Pandion Therapeutics (19), Passage Bio (19), Chinook Therapeutics (19) and RayzeBio (19).
How do I contact VectivBio investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.